Displaying 21 to 30 of 30 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Sequoia Pharmaceuticals Inc Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. |
United States | N/A |
||
|
|
Synovex Corp |
United States | N/A |
||
|
|
Tercica Inc A biopharmaceutical company developing new therapeutics for endocrine system disorders. |
United States | N/A |
||
|
|
Vanda Pharmaceuticals Inc Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. |
United States | N/A |
||
|
|
VaxInnate Corp |
United States | N/A |
||
|
|
VaxInnate Inc A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. |
United States | 25 Oct 2006 | Series C |
|
|
|
VentiRx Pharmaceuticals Inc |
United States | N/A |
||
|
|
Virdante Pharmaceuticals Inc A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. |
United States | 31 Dec 2008 | Series A |
|
|
|
VLST Corp |
United States | N/A |
||
|
|
Xencor Inc Provider of protein engineering technology platforms in the biotechnology industry. |
United States | N/A |